Crossmark

K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas

Crossref DOI link: https://doi.org/10.1038/s41588-022-01205-w

Published Online: 2022-12-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jessa, Selin https://orcid.org/0000-0003-4192-6523
Mohammadnia, Abdulshakour

Harutyunyan, Ashot S. https://orcid.org/0000-0002-9050-9315
Hulswit, Maud

Varadharajan, Srinidhi https://orcid.org/0000-0002-2033-0758
Lakkis, Hussein

Kabir, Nisha

Bashardanesh, Zahedeh

Hébert, Steven https://orcid.org/0000-0001-6267-8595
Faury, Damien

Vladoiu, Maria C. https://orcid.org/0000-0001-8644-0581
Worme, Samantha

Coutelier, Marie

Krug, Brian

Faria Andrade, Augusto

Pathania, Manav

Bajic, Andrea https://orcid.org/0000-0002-7177-5757
Weil, Alexander G.

Ellezam, Benjamin https://orcid.org/0000-0002-8716-7924
Atkinson, Jeffrey

Dudley, Roy W. R.

Farmer, Jean-Pierre

Perreault, Sebastien

Garcia, Benjamin A.

Larouche, Valérie

Blanchette, Mathieu

Garzia, Livia

Bhaduri, Aparna https://orcid.org/0000-0003-4625-6899
Ligon, Keith L. https://orcid.org/0000-0002-7733-600X
Bandopadhayay, Pratiti https://orcid.org/0000-0002-4175-4760
Taylor, Michael D. https://orcid.org/0000-0001-7009-3466
Mack, Stephen C. https://orcid.org/0000-0001-9620-4742
Jabado, Nada https://orcid.org/0000-0003-2485-3692
Kleinman, Claudia L. https://orcid.org/0000-0002-5158-7126
License Information

Text and Data Mining valid from 2022-12-01

Version of Record valid from 2022-12-01
More Information

Article History

Received: 12 November 2021

Accepted: 16 September 2022

First Online: 5 December 2022

Competing interests

: S.P. is a member of the advisory board for Bayer, Novartis and AstraZeneca and has received speaker fees from Bayer and Esai outside of the submitted work. All other authors declare no competing interests.

Document is current

Any future updates will be listed below